Lilly (China)

中国 · 机构编号 I4210152481

检索本机构文献

1本站收录论文

4这些论文的被引

1本站 h 指数

100%开放获取

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

Tongji University中国1
People's Hospital of Xinjiang Uygur Autonomous Region中国1
Wuhan Union Hospital中国1
Longgang Central Hospital中国1
Southern Medical University Shenzhen Hospital中国1
Ningbo First Hospital中国1
Tianjin Medical University General Hospital中国1
Ningxia Medical University General Hospital中国1

按月发文

逐年被引

最新文献

1
The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational StudyDrug Safety20244

高被引文献

1
The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational StudyDrug Safety20244

主要发表期刊

机构信息来自 OpenAlex 的作者单位；一篇文章里同一机构有几位作者只算一篇。统计只算本站收录的论文。